State Primary Care Associations
Overview
HealthHIV, in partnership with select state primary care association (PCAs) offers attendees at PCA conferenced the opportunity to participate in a highly interactive, half-day, CME/CE certified workshop to improve clinician knowledge and competence in screening and testing patients for HIV, improve linkage to expert care, and optimizing initial antiretroviral therapy. The workshop addresses practice gaps in screening, diagnosis, and initial management of HIV using educational interventions appropriate for primary care providers. Included in the workshop are case vignettes, roundtable and small group discussions, and plenty of interaction with expert faculty. To learn more about upcoming PCA workshops please email HealthHIV by
Workshop Name
"Initiative to Educate Primary Care Clinicians in HIV Care: Optimizing Early HIV Screening, Disease Diagnosis, and Access to Expert Care"
Audience
Doctors, Nurse Practitioners, Dentists, Physician Assistants, & Nurses
Learning Objectives
Upon completion of this workshop, participants will be able to:
- Apply recommendations and procedures for primary care practice treatment teams in the screening, diagnosing, and counseling of HIV.
- Develop linkages to care for patients newly diagnosed with HIV to ensure receipt of expert HIV care
from knowledgeable, experienced professionals. - Evaluate factors in the decision to become an expert HIV care giver.
- Describe recommendations in current HIV treatment guidelines on therapy initiation and monitoring of effects of initial regimens.
Workshop Agenda
- Welcome & Introduction by nationally recognized opinion leader
- Review of epidemiological data
- Review of CDC guidelines
- Review of primary care practice gaps
- Interactive session with primary care provider faculty on developing HIV practices
- Presentation of case vignettes
- Small group discussions
Summary
HealthHIV has developed a highly interactive, half-day, CME/CE certified workshop for attendees at state and territorial primary care associations. The workshop allows primary care provider to improve clinical knowledge and competence in screening and testing patients for HIV, improve linkage to expert care, and optimize initial antiretroviral therapy.
While AIDS-defining illness and mortality in the United States is in decline, new data indicates higher than expected annual rates of infection. In 2008 the CDC estimated 1.1 million Americans were living with HIV and that in 2006 there were more than 56,000 new HIV infections in the United States.
In addition to an increase in new HIV cases, recently revised treatment guidelines recommend earlier initiation of antiretroviral therapy which places greater importance on improved linkages to care and education for primary care providers interested in managing patients with HIV. Finally, recently enacted health care reform is expanding coverage to 32 million previously uninsured individuals whose health care concerns, including HIV, will be directed, in many cases, to sites providing primary care.
HealthHIV has identified three important issues facing primary care providers developing HIV practices: screening and testing, improving access to care, and optimizing initial antiretroviral therapy. In this workshop HealthHIV will address these practice gaps and introduce clinicians to resources to expand and improve HIV care.
CME/CE Credits
- Physicians -- 3.0 AMA PRA Category 1 Credit(s)TM
- Nurses -- Credit(s) to be determined
This workshop is developed through a partnership with HealthHIV and DIME, which provides CME/CE Accreditation. DIME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This activity has been approved for AMA PRA Category 1 CreditTM.
DIME is an approved provider of continuing nursing education by the Illinois Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. Contact hours will be awarded for this educational activity.
The activity is supported by an educational grant from Bristol-Myers Squibb Company.


















